Insider · CIK 0001380710

Davis George Eric

Reports to the SEC for 1 company · SAN RAFAEL, CA

sec.gov

Transactions

Companies

Filings

CIK

0001380710

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-02	BMRNBIOMARIN PHARMACEUTICAL INCS Sale	EVP, Chief Legal Officer	SSale	−17.6K sh	$66.28	−$1.16M	61,003
2026-03-18	BMRNBIOMARIN PHARMACEUTICAL INCF Tax Payment	EVP, Chief Legal Officer	FTax Payment	−1,273 sh	$56.05	−$71.4K	78,560
2026-03-16	BMRNBIOMARIN PHARMACEUTICAL INCF Tax Payment	EVP, Chief Legal Officer	FTax Payment	−7,177 sh	$58.51	−$420K	65,263
2026-03-16	BMRNBIOMARIN PHARMACEUTICAL INCA Award	EVP, Chief Legal Officer	AAward	+14.6K sh	—	—	79,833
2026-03-16	BMRNBIOMARIN PHARMACEUTICAL INC · Stock Option (Right to Buy Common Stock)A Award	EVP, Chief Legal Officer	AAward	+34.7K sh	—	—	34,690
2026-02-26	BMRNBIOMARIN PHARMACEUTICAL INCS Sale	EVP, Chief Legal Officer	SSale	−26.1K sh	$61.36	−$1.6M	72,453
2026-02-25	BMRNBIOMARIN PHARMACEUTICAL INCA Award	EVP, Chief Legal Officer	AAward	+6,177 sh	—	—	89,467
2026-02-25	BMRNBIOMARIN PHARMACEUTICAL INCA Award	EVP, Chief Legal Officer	AAward	+6,675 sh	—	—	96,142
2026-02-25	BMRNBIOMARIN PHARMACEUTICAL INCA Award	EVP, Chief Legal Officer	AAward	+2,372 sh	—	—	98,514
2025-04-30	BMRNBIOMARIN PHARMACEUTICAL INCA Award	EVP, Chief Legal Officer	AAward	+375 sh	$54.14	+$20.3K	83,290
2025-03-17	BMRNBIOMARIN PHARMACEUTICAL INCA Award	EVP, Chief Legal Officer	AAward	+12.9K sh	—	—	82,915
2025-03-17	BMRNBIOMARIN PHARMACEUTICAL INC · Stock Option (Right to Buy Common Stock)A Award	EVP, Chief Legal Officer	AAward	+30K sh	—	—	30,020
2025-03-14	BMRNBIOMARIN PHARMACEUTICAL INCF Tax Payment	EVP, Chief Legal Officer	FTax Payment	−16.2K sh	$69.44	−$1.13M	69,975
2025-02-25	BMRNBIOMARIN PHARMACEUTICAL INCA Award	EVP, Chief Legal Officer	AAward	+11K sh	—	—	67,197
2025-02-25	BMRNBIOMARIN PHARMACEUTICAL INCA Award	EVP, Chief Legal Officer	AAward	+9,660 sh	—	—	76,857
2025-02-25	BMRNBIOMARIN PHARMACEUTICAL INCA Award	EVP, Chief Legal Officer	AAward	+9,367 sh	—	—	86,224
2024-05-28	BMRNBIOMARIN PHARMACEUTICAL INCM Exercise/Conversion	EVP, Chief Legal Officer	MExercise/Conversion	+40.9K sh	$63.10	+$2.58M	97,007
2024-05-28	BMRNBIOMARIN PHARMACEUTICAL INCS Sale	EVP, Chief Legal Officer	SSale	−38.1K sh	$74.45	−$2.83M	58,936
2024-05-28	BMRNBIOMARIN PHARMACEUTICAL INCS Sale	EVP, Chief Legal Officer	SSale	−2,779 sh	$75.29	−$209K	56,157
2024-05-28	BMRNBIOMARIN PHARMACEUTICAL INC · Stock Option (Right to Buy Common Stock)M Exercise/Conversion	EVP, Chief Legal Officer	MExercise/Conversion	−40.9K sh	—	—	0
2024-05-02	BMRNBIOMARIN PHARMACEUTICAL INCM Exercise/Conversion	EVP, Chief Legal Officer	MExercise/Conversion	+1,850 sh	$63.10	+$117K	58,007
2024-05-02	BMRNBIOMARIN PHARMACEUTICAL INCS Sale	EVP, Chief Legal Officer	SSale	−1,850 sh	$85.01	−$157K	56,157
2024-05-02	BMRNBIOMARIN PHARMACEUTICAL INC · Stock Option (Right to Buy Common Stock)M Exercise/Conversion	EVP, Chief Legal Officer	MExercise/Conversion	−1,850 sh	—	—	40,850
2024-04-30	BMRNBIOMARIN PHARMACEUTICAL INCA Award	EVP, Chief Legal Officer	AAward	+301 sh	$68.65	+$20.7K	56,157
2024-03-28	BMRNBIOMARIN PHARMACEUTICAL INCS Sale	EVP, Chief Legal Officer	SSale	−24.6K sh	$88.34	−$2.17M	55,856
2024-03-15	BMRNBIOMARIN PHARMACEUTICAL INCA Award	EVP, Chief Legal Officer	AAward	+10.3K sh	—	—	102,157
2024-03-15	BMRNBIOMARIN PHARMACEUTICAL INCF Tax Payment	EVP, Chief Legal Officer	FTax Payment	−21.7K sh	$83.87	−$1.82M	80,458
2024-03-15	BMRNBIOMARIN PHARMACEUTICAL INC · Stock Option (Right to Buy Common Stock)A Award	EVP, Chief Legal Officer	AAward	+23K sh	—	—	22,990
2024-02-27	BMRNBIOMARIN PHARMACEUTICAL INCA Award	EVP, Chief Legal Officer	AAward	+20.8K sh	—	—	76,550
2024-02-27	BMRNBIOMARIN PHARMACEUTICAL INCA Award	EVP, Chief Legal Officer	AAward	+9,063 sh	—	—	85,613
2024-02-27	BMRNBIOMARIN PHARMACEUTICAL INCA Award	EVP, Chief Legal Officer	AAward	+6,284 sh	—	—	91,897
2023-12-13	BMRNBIOMARIN PHARMACEUTICAL INCS Sale	EVP, Chief Legal Officer	SSale	−13.8K sh	$95.30	−$1.31M	55,710
2023-08-08	BMRNBIOMARIN PHARMACEUTICAL INCS Sale	EVP, Chief Legal Officer	SSale	−11K sh	$89.42	−$984K	69,474
2023-05-16	BMRNBIOMARIN PHARMACEUTICAL INCG Gift	EVP, Chief Legal Officer	GGift	−210 sh	—	—	80,474
2023-04-28	BMRNBIOMARIN PHARMACEUTICAL INCA Award	EVP, Chief Legal Officer	AAward	+317 sh	$66.88	+$21.2K	80,684
2023-03-16	BMRNBIOMARIN PHARMACEUTICAL INCF Tax Payment	EVP, Chief Legal Officer	FTax Payment	−20K sh	$93.41	−$1.86M	80,367
2023-03-15	BMRNBIOMARIN PHARMACEUTICAL INCA Award	EVP, Chief Legal Officer	AAward	+8,900 sh	—	—	103,349
2023-03-15	BMRNBIOMARIN PHARMACEUTICAL INCF Tax Payment	EVP, Chief Legal Officer	FTax Payment	−3,025 sh	$87.74	−$265K	100,324
2023-03-15	BMRNBIOMARIN PHARMACEUTICAL INC · Stock Option (Right to buy Common Stock)A Award	EVP, Chief Legal Officer	AAward	+20.3K sh	—	—	20,320
2023-02-28	BMRNBIOMARIN PHARMACEUTICAL INCA Award	EVP, Chief Legal Officer	AAward	+20.2K sh	—	—	76,925
2023-02-28	BMRNBIOMARIN PHARMACEUTICAL INCA Award	EVP, Chief Legal Officer	AAward	+10.1K sh	—	—	87,025
2023-02-28	BMRNBIOMARIN PHARMACEUTICAL INCA Award	EVP, Chief Legal Officer	AAward	+7,424 sh	—	—	94,449
2023-02-24	BMRNBIOMARIN PHARMACEUTICAL INCM Exercise/Conversion	EVP, Chief Legal Officer	MExercise/Conversion	+1,474 sh	$67.81	+$100K	56,725
2023-02-24	BMRNBIOMARIN PHARMACEUTICAL INC · Stock Option (Right to buy Common Stock)M Exercise/Conversion	EVP, Chief Legal Officer	MExercise/Conversion	−1,474 sh	—	—	0
2022-08-09	BMRNBIOMARIN PHARMACEUTICAL INCS Sale	EVP, Chief Legal Officer	SSale	−3,690 sh	$96.34	−$355K	55,251
2022-08-09	BMRNBIOMARIN PHARMACEUTICAL INCM Exercise/Conversion	EVP, Chief Legal Officer	MExercise/Conversion	+47.5K sh	$67.81	+$3.22M	102,777
2022-08-09	BMRNBIOMARIN PHARMACEUTICAL INCS Sale	EVP, Chief Legal Officer	SSale	−47.5K sh	$95.93	−$4.56M	55,251
2022-08-09	BMRNBIOMARIN PHARMACEUTICAL INC · Stock Option (Right to buy Common Stock)M Exercise/Conversion	EVP, Chief Legal Officer	MExercise/Conversion	−47.5K sh	—	—	0
2022-07-08	BMRNBIOMARIN PHARMACEUTICAL INCS Sale	EVP, Chief Legal Officer	SSale	−7,398 sh	$90.00	−$666K	58,941
2022-05-02	BMRNBIOMARIN PHARMACEUTICAL INCM Exercise/Conversion	EVP, Chief Legal Officer	MExercise/Conversion	+15.3K sh	$37.46	+$575K	81,686

Recent filings

Accepted (ET)
Sep 34
Davis George Eric0001628280-26-060572
SEC(opens sec.gov)
Mar 194
Davis George Eric0001628280-26-019862
SEC(opens sec.gov)
Mar 174
Davis George Eric0001628280-26-019010
SEC(opens sec.gov)
Feb 264
Davis George Eric0001628280-26-012533
SEC(opens sec.gov)
Feb 135
Davis George Eric0001628280-26-008216
SEC(opens sec.gov)
Mar 184
Davis George Eric0001048477-25-000037
SEC(opens sec.gov)
Feb 274
Davis George Eric0001048477-25-000015
SEC(opens sec.gov)
May 304
Davis George Eric0001048477-24-000112
SEC(opens sec.gov)

Companies

BIOMARIN PHARMACEUTICAL INCEVP, Chief Legal OfficerBMRN

Address

C/O BIOMARIN PHARMACEUTICAL INC. 770 LINDARO STREET

SAN RAFAEL, CA, 94901